HomeCompareEPIX vs JEPQ

EPIX vs JEPQ: Dividend Comparison 2026

EPIX yields 840.47% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EPIX wins by $4215412.24M in total portfolio value
10 years
EPIX
EPIX
● Live price
840.47%
Share price
$0.20
Annual div
$1.69
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4215412.28M
Annual income
$3,415,908,279,597.25
Full EPIX calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — EPIX vs JEPQ

📍 EPIX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEPIXJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EPIX + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EPIX pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EPIX
Annual income on $10K today (after 15% tax)
$71,440.13/yr
After 10yr DRIP, annual income (after tax)
$2,903,522,037,657.66/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, EPIX beats the other by $2,903,522,035,827.96/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EPIX + JEPQ for your $10,000?

EPIX: 50%JEPQ: 50%
100% JEPQ50/50100% EPIX
Portfolio after 10yr
$2107706.16M
Annual income
$1,707,954,140,874.91/yr
Blended yield
81.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPIX right now

EPIX
Analyst Ratings
2
Buy
3
Hold
Consensus: Hold
Price Target
$9.50
+4621.7% upside vs current
Range: $2.00 — $17.00
Altman Z
1.1
Piotroski
3/9
JEPQ
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EPIX buys
0
JEPQ buys
0
No recent congressional trades found for EPIX or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEPIXJEPQ
Forward yield840.47%11.10%
Annual dividend / share$1.69$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4215412.28M$44.8K
Annual income after 10y$3,415,908,279,597.25$2,152.59
Total dividends collected$4152700.41M$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: EPIX vs JEPQ ($10,000, DRIP)

YearEPIX PortfolioEPIX Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$94,747$84,047.22$11,930$1,110.39+$82.8KEPIX
2$845,608$744,228.02$14,133$1,224.34+$831.5KEPIX
3$7,112,413$6,207,612.95$16,632$1,340.46+$7.10MEPIX
4$56,406,815$48,796,533.54$19,454$1,457.97+$56.39MEPIX
5$422,031,389$361,676,096.60$22,626$1,576.08+$422.01MEPIX
6$2,980,575,750$2,529,002,163.86$26,175$1,694.09+$2980.55MEPIX
7$19,881,694,862$16,692,478,809.61$30,133$1,811.32+$19881.66MEPIX
8$125,334,964,899$104,061,551,396.31$34,531$1,927.17+$125334.93MEPIX
9$747,200,001,618$613,091,589,175.98$39,403$2,041.08+$747199.96MEPIX
10$4,215,412,281,328$3,415,908,279,597.25$44,787$2,152.59+$4215412.24MEPIX

EPIX vs JEPQ: Complete Analysis 2026

EPIXStock

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Full EPIX Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this EPIX vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EPIX vs SCHDEPIX vs JEPIEPIX vs OEPIX vs KOEPIX vs MAINEPIX vs XYLDEPIX vs QYLDEPIX vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.